Related Experiment Video
Updated: May 3, 2026

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Impaired Growth during Childhood in Patients with Primary Ciliary Dyskinesia
Tamara Svobodová1, Jana Djakow1, Daniela Zemková1
1Department of Pediatrics, 2nd Faculty of Medicine, University Hospital Motol, Charles University, 150 06 Prague, Czech Republic.
Insights
Primary ciliary dyskinesia (PCD) causes chronic respiratory infections and significant growth delays in children. This study found children with PCD experience progressive height deterioration, particularly those with DNAH5 or DNAI1 mutations.
Area of Science:
- Pediatrics
- Genetics
- Pulmonology
Background:
- Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by impaired ciliary function.
- PCD leads to recurrent respiratory infections, chronic inflammation, and potential development of chronic pulmonary disease and bronchiectasis.
- Growth delay and nutritional deficits are potential complications of chronic childhood illnesses.
Purpose of the Study:
- To analyze longitudinal growth patterns (height and BMI) in children and young adults diagnosed with Primary Ciliary Dyskinesia (PCD).
- To investigate the relationship between PCD, genetic mutations (DNAH5, DNAI1), and growth deterioration.
- To determine if nutritional deficits contribute to growth delay in PCD patients.
Main Methods:
- Longitudinal data analysis of body length/height and BMI in 29 children and young adults with PCD (ages 1.5-24 years).
- Diagnosis ages ranged from 0.5-17 years.
- Genetic analysis was performed on a subset of patients, with 10 carrying mutations in DNAH5 or DNAI1.
Main Results:
- Children with PCD showed a progressive decrease in height standard deviation scores (SDS) from age 1 to 13 years (P=0.01 to P=0.005).
- Height deterioration was more pronounced in patients with DNAH5 or DNAI1 mutations.
- Body Mass Index (BMI) remained within population standards, suggesting growth delay is not due to nutritional deficits.
Conclusions:
- Primary ciliary dyskinesia (PCD) is associated with significant growth deterioration during childhood.
- The observed growth delay in PCD is likely a consequence of chronic illness rather than nutritional deficits.
- Genetic factors, specifically DNAH5 and DNAI1 mutations, may influence the severity of growth impairment in PCD.
Abstract:
Primary ciliary dyskinesia (PCD) leads to recurrent/chronic respiratory infections, resulting in chronic inflammation and potentially in chronic pulmonary disease with bronchiectasis. We analyzed longitudinal data on body length/height and body mass index (BMI) for 29 children and young adults with PCD aging 1.5-24 years (median, 14.5) who had been diagnosed at the age of 0.5-17 years (median, 8). Of these, 10 carried pathogenic mutations in either DNAH5 or DNAI1. In children with PCD, body length/height progressively decreased from +0.40 ± 0.24 SDS (the 1st birthday), +0.16 ± 0.23 SDS (3 years old), and -0.13 ± 0.21 SDS (5 years old) to -0.54 ± 0.19 SDS (7 years old; P = 0.01 versus 0), -0.67 ± 0.21 SDS (9 years old; P = 0.005 versus 0), -0.52 ± 0.24 SDS (11 years old; P = 0.04 versus 0), and -0.53 ± 0.23 SDS (13 years old; P = 0.03 versus 0). These results reflect low growth rates during the childhood growth period. Thereafter, heights stabilized up to the age of 17 years. The growth deterioration was not dependent on sex or disease severity but was more pronounced in DNAH5 or DNAI1 mutation carriers. BMI did not differ from population standards, which suggests that nutritional deficits are not the cause of growth delay. We conclude that PCD leads to chronic deprivation with significant growth deterioration during childhood.
More Related Videos
05:32High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022
11:13Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
Published on: November 10, 2021
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Microtubules in Signaling
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation